Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
WANBURY | NSE
-3.50
-1.34%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
258.22
255.10
266.00
253.50
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology orthopedics heamatinics anti-diabetic nutraceuticals gastro intestinal stroke surgery antibiotics cough and cold solutions anti-inflammatory analgesics and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic anti-analgesic anti-depressant anti-histaminic anti-inflammatory anti-arthritis anti-thrombotic anti-epileptic and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
48.5%1 month
48.5%3 months
70.8%6 months
58.9%15.72
-
29.32
4.17
0.34
9.51
1.63
-
683.94M
8.46B
88.37M
-
5.86
-78.30
-10.40
51.37
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
46.65
Range1M
59.70
Range3M
122.50
Rel. volume
0.42
Price X volume
6.10M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 96.42 | 8.94B | 0.79% | 49.05 | 25.36% |
| Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 137.4 | 8.12B | -0.41% | 1.92 | 1.78% |
| TAKE Solutions Limited | TAKE | Biotechnology | 46.26 | 6.84B | -1.99% | n/a | -417.95% |
| Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 199.2 | 5.28B | -1.40% | 61.65 | 4.77% |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 89.11 | 5.28B | -3.75% | 20.75 | 2.03% |
| Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 83.65 | 4.08B | -0.85% | 29.93 | 45.58% |
| Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 697.3 | 4.00B | -2.67% | 9.51 | 0.87% |
| Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 40.86 | 3.25B | -2.51% | 45.53 | 15.37% |
| Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 136.02 | 3.23B | -0.73% | 674.92 | 30.17% |
| Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 257.66 | 3.18B | -0.70% | 82.74 | 15.37% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.51 | 24.85 | Cheaper |
| Ent. to Revenue | 1.63 | 11.40 | Cheaper |
| PE Ratio | 15.72 | 51.36 | Cheaper |
| Price to Book | 29.32 | 6.83 | Expensive |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 70.78 | 42.17 | Riskier |
| Debt to Equity | 4.17 | 0.35 | Expensive |
| Debt to Assets | 0.34 | 0.17 | Expensive |
| Market Cap | 8.46B | 290.82B | Emerging |